Business · 25/10/2007Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Blood Collection Information Collection Under Paperwork Reduction Act
Summary
The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information related to the handling of blood and blood components at increased risk of transmitting HCV infection, as part of the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →